BofA Upgrades Agilent Technologies to Buy From Neutral, Price Target is $145

Leerink Partners Upgrades Equillium to Outperform From Market Perform, Adjusts PT to $6 From $1

Equillium (EQ) has an average rating of buy and mean price target of $7.12, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

Barclays Downgrades PDD Holdings to Equalweight From Overweight, Adjusts PT to $89 From $165

PDD Holdings (PDD) has an average rating of overweight and mean price target of $133.48, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

Truist Initiates Organogenesis Holdings at Hold With $3 Price Target